Deutschland - Arzneimittel - Bekanntmachung vergebener Aufträge nach §130 a Abs. 8 SGB V und §130 c SGB V zu dem Wirkstoff Ruxolitinib (Opzelura Creme)

different companies won its awards

34

of the awards went to the three most frequent winners

15%

of its calls state an estimated value

0%

Based on 39 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Competition

tenders per lot on average (open and restricted procedures)

3.5

of those lots received a single tender

13%

of the awards went to companies based in another country

6%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.

Germany · Medical equipment & pharmaceuticals

different companies won awards here

806

of the awards went to the three most frequent winners

9%

buyers awarded contracts here

447

Based on 1,527 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Competition

tenders per lot on average (open and restricted procedures)

12.2

of those lots received a single tender

16%

of the awards went to companies based in another country

7%

of the tenders came from another country

6%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.